Atomic structure of anthrax protective antigen pore elucidates toxin translocation

Nature
Jiansen JiangZ Hong Zhou

Abstract

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Protective antigen forms oligomeric prepores that undergo conversion to membrane-spanning pores by endosomal acidification, and these pores translocate the enzymes lethal factor and oedema factor into the cytosol of target cells. Protective antigen is not only a vaccine component and therapeutic target for anthrax infections but also an excellent model system for understanding the mechanism of protein translocation. On the basis of biochemical and electrophysiological results, researchers have proposed that a phi (Φ)-clamp composed of phenylalanine (Phe)427 residues of protective antigen catalyses protein translocation via a charge-state-dependent Brownian ratchet. Although atomic structures of protective antigen prepores are available, how protective antigen senses low pH, converts to active pore, and translocates lethal factor and oedema factor are not well defined without an atomic model of its pore. Here, by cryo-electron microscopy with direct electron counting, we determine the protective antigen pore structure at 2.9-Å resolution. T...Continue Reading

References

Feb 27, 1997·Nature·C PetosaR C Liddington
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Dec 22, 1999·Journal of Structural Biology·S J LudtkeW Chiu
Sep 6, 2000·Trends in Biochemical Sciences·J A Killian, G von Heijne
Dec 13, 2000·The Journal of Biological Chemistry·B R SellmanR J Collier
Jul 27, 2001·Journal of Structural Biology·J B Heymann
Jun 5, 2003·Journal of Structural Biology·Joseph A Mindell, Nikolaus Grigorieff
Nov 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Michael MourezRodney K Tweten
Mar 27, 2004·The Journal of Biological Chemistry·Darran J WigelsworthR John Collier
Jul 10, 2004·Nature·Eugenio SantelliRobert C Liddington
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Aug 25, 2004·Proceedings of the National Academy of Sciences of the United States of America·D Borden LacyR John Collier
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
May 14, 2005·Journal of Structural Biology·Christian SulowayBridget Carragher
May 26, 2005·Bioinformatics·Liskin Swint-Kruse, Curties S Brown
Dec 14, 2005·Journal of Molecular Biology·Bryan A KrantzR John Collier
Dec 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Guy ZivD Thirumalai
Jun 21, 2006·Journal of Molecular Biology·N R VossP B Moore
Jun 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Roman A Melnyk, R John Collier
Mar 6, 2007·Annual Review of Biochemistry·John A T Young, R John Collier
Aug 8, 2007·Journal of Molecular Biology·Evgeny Krissinel, Kim Henrick
Oct 30, 2008·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Alan Finkelstein
Feb 11, 2009·The Journal of General Physiology·Daniel BasilioAlan Finkelstein
Apr 14, 2009·Journal of Structural Biology·Christian SulowayGrant J Jensen
Jul 18, 2009·Protein Science : a Publication of the Protein Society·Gregory VernierR John Collier
Jul 25, 2009·Journal of Molecular Biology·Alexander F KintzerBryan A Krantz
Jan 12, 2010·The Journal of Biological Chemistry·Blythe E JanowiakR John Collier
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Nov 3, 2010·Nature Structural & Molecular Biology·Geoffrey K FeldBryan A Krantz
Apr 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Swastik De, Rich Olson
Apr 22, 2011·The Journal of Biological Chemistry·Michael J BrownBryan A Krantz
Nov 22, 2011·Journal of Molecular Biology·Sjors H W Scheres
Mar 1, 2012·Protein Science : a Publication of the Protein Society·Geoffrey K FeldBryan A Krantz
Sep 25, 2012·Journal of Structural Biology·Sjors H W Scheres
Oct 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Alexander F KintzerBryan A Krantz
Nov 2, 2012·The Journal of Biological Chemistry·Sarah L Wynia-SmithBryan A Krantz
Aug 21, 2013·Journal of Cheminformatics·David SehnalJaroslav Koča
Mar 29, 2014·Science·Alexey AmuntsV Ramakrishnan
Apr 30, 2014·Journal of Computer-aided Molecular Design·Nils OberhauserPierre-Alain Carrupt

❮ Previous
Next ❯

Citations

Jul 17, 2015·Expert Opinion on Drug Discovery·Heping ZhengWladek Minor
Oct 27, 2015·Current Opinion in Structural Biology·Olwyn Byron, Bente Vestergaard
Dec 17, 2015·Microscopy·Yong Zi TanBridget Carragher
Dec 15, 2015·Journal of Molecular Modeling·Laleh Alisaraie, Isabelle Rouiller
Sep 13, 2015·Journal of Molecular Biology·Jennifer M Colby, Bryan A Krantz
Nov 26, 2015·Current Opinion in Structural Biology·Peter B Rosenthal, John L Rubinstein
Mar 5, 2016·The Journal of Chemical Physics·Dmitry Shorokhov, Ahmed H Zewail
Nov 26, 2015·Journal of Structural Biology·Kai Zhang
Dec 15, 2015·Pathogens and Disease·Sergey M Bezrukov, Ekaterina M Nestorovich
Feb 13, 2016·IUCrJ·Sriram SubramaniamRichard Henderson
Dec 8, 2015·Nature Reviews. Microbiology·Matteo Dal Peraro, F Gisou van der Goot
Jul 15, 2015·The Journal of General Physiology·Aviva SchiffmillerAlan Finkelstein
Jan 26, 2016·ACS Central Science·Amy E Rabideau, Bradley L Pentelute
Oct 27, 2015·Chemical Society Reviews·Bas J G E PietersJasmin Mecinović
Oct 7, 2015·Trends in Microbiology·Nani Van GervenHan Remaut
Nov 8, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Paul D R DyerSimon C W Richardson
Mar 22, 2016·Ultramicroscopy·P KruitK K Berggren
Nov 27, 2015·Biochimica Et Biophysica Acta·Cyril F ReboulMichelle A Dunstone
Oct 6, 2015·Current Opinion in Structural Biology·Kutti R Vinothkumar
Mar 16, 2016·Toxins·Sarah FriebeJérôme Bürgi
Mar 30, 2016·Nature Communications·Kevin W HuynhVera Y Moiseenkova-Bell
Aug 12, 2015·Toxicon : Official Journal of the International Society on Toxinology·Roger M BenoitRichard A Kammerer
Apr 26, 2016·Chemical Reviews·Stephen Boulton, Giuseppe Melacini
Apr 9, 2016·ACS Chemical Biology·Amy E Rabideau, Bradley Lether Pentelute
Jul 21, 2016·Journal of Structural Biology·Muyuan ChenMatthew L Baker
Aug 11, 2016·Proceedings of the National Academy of Sciences of the United States of America·Debasis Das, Bryan A Krantz
Aug 30, 2016·Nature Structural & Molecular Biology·Christos GatsogiannisStefan Raunser
Oct 17, 2015·Journal of Structural Biology·Dario Oliveira Passos, Dmitry Lyumkis
Sep 28, 2016·The Journal of General Physiology·Lucien FabreIsabelle Rouiller
Sep 22, 2016·Langmuir : the ACS Journal of Surfaces and Colloids·Jamie LeBarron, Erwin London
Sep 28, 2016·Protein Science : a Publication of the Protein Society·Yoshimasa TakizawaMelanie D Ohi
Jan 25, 2017·Journal of Molecular Biology·Debasis Das, Bryan A Krantz
Nov 20, 2016·Angewandte Chemie·Felipe Merino, Stefan Raunser
Jul 17, 2015·Scientific Reports·Amy E RabideauBradley L Pentelute
Jun 13, 2015·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Hong YiElizabeth R Wright

❮ Previous
Next ❯

Software Mentioned

CTFFIND
EMAN
Coot
ResMap
PHENIX
Bsoft
Leginon automation
PyMOL
RELION
CNS

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

© 2021 Meta ULC. All rights reserved